Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SNGX stock hub

Soligenix, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SNGXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
SNGX
In the news

Latest news · SNGX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-326.9
P25 -105.6P50 -46.5P75 -3.1
ROIC-205.7
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SNGX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
190
Groups with data
11
Currency
USD
Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0000812796
Company name
Soligenix, Inc.
Country
United States
Country code
US
Cusip
834223604
Employees
14
Employees Change
-2%
Employees Change Percent
-12.5
Enterprise value
$-2.7M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
1987-06-15
Isin
US8342236044
Last refreshed
2026-05-10
Market cap
$3M
Market cap category
Nano-Cap
Price
$0.29
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
SNGX
Website
https://www.soligenix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-362.76%
FCF yield
-357.1%
P/B ratio
1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
$-11M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Profit Per Employee
$-782,434
ROA
-99.73
Roa5y
-52.49
ROCE
-354.3
ROE
-326.9
Roe5y
-4,955.2
ROIC
-205.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
-58.67%
Cagr15y
-50.24%
Cagr1y
-85.15%
Cagr20y
-41.87%
Cagr3y
-74.46%
Cagr5y
-75.12%
EPS Growth Quarters
14
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$6.9M
Cash
$6M
Current Assets
$6.6M
Current Liabilities
$3.6M
Debt
$330,660
Debt Equity
$0.11
Equity
$3.1M
Liabilities
$3.8M
Long Term Assets
$357,392
Long Term Liabilities
$213,425
Net Cash
$5.7M
Net Cash By Market Cap
$189
Net Cash Growth
-21.05%
Net Debt Equity
$-1.84
Tangible Book Value
$3.1M
Tangible Book Value Per Share
$0.29
WACC
10.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.81
Net Working Capital
$-3M
Quick ratio
1.67
Working Capital
$2.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-208.52%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
-99.99%
1Y total return
-85.13%
200-day SMA
1.61
3Y total return
-98.34%
50-day SMA
1.05
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.9%
All Time High
6,660,426.3
All Time High Change
-100%
All Time High Date
1992-09-29
All Time Low
0.29
All Time Low Change
0.93%
All Time Low Date
2026-05-08
ATR
0.09
Beta
1.32
Beta1y
-1.97
Beta2y
0.21
Ch YTD
-78.13
High
0.33
High52
6.23
High52 Date
2025-08-18
High52ch
-95.3%
Low
0.29
Low52
0.29
Low52 Date
2026-05-08
Low52ch
0.93%
Ma50ch
-72.15%
Premarket Change Percent
-1.43
Premarket Price
$0.3
Premarket Volume
21,359
Price vs 200-day SMA
-81.78%
RSI
18.91
RSI Monthly
33.13
RSI Weekly
27.03
Sharpe ratio
-0.16x
Sortino ratio
-0.27
Total Return
-208.52%
Tr YTD
-78.13
Tr15y
-100%
Tr1m
-74.3%
Tr1w
-15.07%
Tr3m
-74.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Analyst Count
1
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.25
Operating Income
$-11.7M
Price target
$6
Price Target Change
$1,948

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
9,760,548%
Float Percent
94.71%
Shares Insiders
0.15%
Shares Institutions
8.47%
Shares Out
10,306,079
Shares Qo Q
0.81%
Shares Yo Y
208.52%
Short Float
8.29%
Short Ratio
2.46
Short Shares
7.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-11.5M
Average Volume
1,457,578.1x
Bv Per Share
0.29
CAPEX
$-5,883
Ch10y
-99.99
Ch15y
-100
Ch1m
-74.3
Ch1w
-15.07
Ch1y
-85.13
Ch20y
-100
Ch3m
-74.07
Ch3y
-98.34
Ch5y
-99.9
Ch6m
-78.61
Change
-4.93%
Change From Open
-11.21
Close
0.31
Days Gap
7.07
Depreciation Amortization
3,714
Dollar Volume
293,992.4
Earnings Date
2026-05-08
Earnings Time
bmo
EBIT
$-11.7M
EBITDA
$-11.7M
EPS
$-1.57
F Score
1
FCF
$-10.8M
FCF EV Yield
402.49x
FCF Per Share
$-1.05
Financing CF
9,515,406
Fiscal Year End
December
Founded
1,987
Income Tax
$-506,615
Investing CF
-5,883
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-08
Last Report Date
2026-03-31
Last Split Date
2024-06-06
Last Split Type
Reverse
Last10k Filing Date
2026-03-31
Ma150
1.29
Ma150ch
-77.22%
Ma20
0.86
Ma20ch
-65.83%
Net CF
-1,267,741
Next Earnings Date
2026-08-13
Open
0.33
Optionable
No
Position In Range
6.8
Post Close
0.29
Postmarket Change Percent
2.39
Postmarket Price
$0.3
Ppne
334,615
Pre Close
0.31
Price Date
2026-05-08
Ptbv Ratio
0.98
Relative Volume
0.69x
Share Based Comp
701,794
Tr20y
-100%
Tr6m
-78.61%
Us State
New Jersey
Volume
1,003,387
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SNGX pay a dividend?

Capital-return profile for this ticker.

Performance

SNGX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-85.1%
S&P 500 1Y: n/a
3Y total return
-98.3%
S&P 500 3Y: n/a
5Y total return
-99.9%
S&P 500 5Y: n/a
10Y total return
-100.0%
S&P 500 10Y: n/a
Ownership

Who owns SNGX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.5%
Float: +94.7% of shares outstanding
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+8.3%
2.5 days to cover
Y/Y dilution
+208.5%
Negative means the company is buying back shares.
Technical

SNGX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
18.9
Below 30: short-term oversold
Price vs 200-day MA
-81.8%
50/200-day relationship not available
Beta (5Y)
1.32
More volatile than the market
Sharpe ratio
-0.16
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SNGX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SNGX stock rating?

Soligenix, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SNGX analysis?

The full report lives at /stocks/SNGX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SNGX?

The latest report frames SNGX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SNGX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.